US company petitions FDA to regulate all IVD tests
This article was originally published in RAJ Devices
US biopharmaceutical company Genentech has filed a citizen petition with the Food and Drug Administration asking the agency to broaden the scope of its regulations to include in vitro diagnostic tests that are developed by clinical laboratory companies for in-house testing to guide therapeutic decision-making1.
You may also be interested in...
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.